Global In-Vitro Diagnostic (IVD) Market: Size, Trends & Forecasts (2017-2021)
SCOPE OF THE REPORT
The report entitled “Global In-Vitro Diagnostic (IVD) Market: Size, Trends & Forecasts (2017-2021)”, provides analysis of the global In-Vitro Diagnostic, with detailed analysis of market size and growth, and segmentation of the industry. The analysis includes the market by value, by products, by technology and by region. The report also provides the analysis of the global in-vitro diagnostic market of the US, Europe, Asia and ROW regions.
Moreover, the report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global in-vitro diagnostic has also been forecasted for the years 2017-2021, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.
Roche Holding, Danaher Corporation, Abbott Laboratories and Siemens Group are some of the key players operating in the global in-vitro diagnostic market, whose company profiling has been done in the report. In this segment of the report, business overview, financial overview and business strategies of the companies are provided.
COUNTRY COVERAGE
Clinical trials are defined as research examinations in which individuals volunteer to test new medications, interferences or tests as a way to prevent, distinguish, treat or oversee different illnesses or medical conditions. The clinical trials can broadly be classified into two categories named as In Vivo and In Vitro.
In vivo indicates to a medical test, trial or strategy that is done on (or in) a living being, for example, a research laboratory animal or human. In vitro refers to a medicinal report or examination which is done in the research facility inside the confines of a test tube or lab dish.
In Vitro Diagnostics (IVD) are medical devices and accessories used to perform tests on biological samples (such as tissues, blood or urine) to determine the status of a person health. The in vitro diagnostics can further be divided on the basis of products, by technology and by end users.
The In Vitro Diagnostics (IVD) is generally divided into three types of products namely, reagents, Instrumentations and Software Services. The IVD is primarily segmented into eight technologies Immunodiagnostics, Self-Monitoring Blood Glucose (SMBG), Point-of-Care, Molecular Diagnostics, Microbiology, Clinical Chemistry, Hematology and Other. The in vitro diagnostic end users are broadly classified into three categories named as Laboratory, Hospitals and Patients Self-Testing.
The global in-vitro diagnostics (IVD) market is expected to increase at high growth rates during the forecasted period (2017-2021). The global in-vitro diagnostics is supported by various growth drivers, such as, increasing disposable income, increasing obese population, swelling diabetic population, rising healthcare expenditure, etc.
The report entitled “Global In-Vitro Diagnostic (IVD) Market: Size, Trends & Forecasts (2017-2021)”, provides analysis of the global In-Vitro Diagnostic, with detailed analysis of market size and growth, and segmentation of the industry. The analysis includes the market by value, by products, by technology and by region. The report also provides the analysis of the global in-vitro diagnostic market of the US, Europe, Asia and ROW regions.
Moreover, the report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global in-vitro diagnostic has also been forecasted for the years 2017-2021, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.
Roche Holding, Danaher Corporation, Abbott Laboratories and Siemens Group are some of the key players operating in the global in-vitro diagnostic market, whose company profiling has been done in the report. In this segment of the report, business overview, financial overview and business strategies of the companies are provided.
COUNTRY COVERAGE
- The US
- Europe
- Asia
- ROW
- Roche Holding
- Danaher Corporation
- Abbott Laboratories
- Siemens Group
Clinical trials are defined as research examinations in which individuals volunteer to test new medications, interferences or tests as a way to prevent, distinguish, treat or oversee different illnesses or medical conditions. The clinical trials can broadly be classified into two categories named as In Vivo and In Vitro.
In vivo indicates to a medical test, trial or strategy that is done on (or in) a living being, for example, a research laboratory animal or human. In vitro refers to a medicinal report or examination which is done in the research facility inside the confines of a test tube or lab dish.
In Vitro Diagnostics (IVD) are medical devices and accessories used to perform tests on biological samples (such as tissues, blood or urine) to determine the status of a person health. The in vitro diagnostics can further be divided on the basis of products, by technology and by end users.
The In Vitro Diagnostics (IVD) is generally divided into three types of products namely, reagents, Instrumentations and Software Services. The IVD is primarily segmented into eight technologies Immunodiagnostics, Self-Monitoring Blood Glucose (SMBG), Point-of-Care, Molecular Diagnostics, Microbiology, Clinical Chemistry, Hematology and Other. The in vitro diagnostic end users are broadly classified into three categories named as Laboratory, Hospitals and Patients Self-Testing.
The global in-vitro diagnostics (IVD) market is expected to increase at high growth rates during the forecasted period (2017-2021). The global in-vitro diagnostics is supported by various growth drivers, such as, increasing disposable income, increasing obese population, swelling diabetic population, rising healthcare expenditure, etc.
1. EXECUTIVE SUMMARY
2. INTRODUCTION
2.1 Clinical Trials: An Overview
2.2 In-Vitro: An Overview
2.3 In-Vitro Diagnostic (IVD): An Overview
2.4 In-Vitro Diagnostic (IVD) Products: An Overview
2.5 In-Vitro Diagnostic (IVD) Technology: An Overview
2.6 In-Vitro Diagnostic (IVD) End Users: An Overview
2.7 In-Vitro Diagnostic (IVD) Research Flow: An Overview
3. GLOBAL MARKET ANALYSIS
3.1 Global In-Vitro Diagnostic Market: An Analysis
3.1.1 Global In-Vitro Diagnostic Market by Value
3.1.2 Global In-Vitro Diagnostic Market by Region
3.1.3 Global In-Vitro Diagnostic Market by Products
3.1.4 Global In-Vitro Diagnostic Market by Technology
3.1.5 Global In-Vitro Diagnostic Market by End Users
3.2 Global In-Vitro Diagnostic Market: Product Analysis
3.2.1 Global In-Vitro Diagnostic Reagents Market by Value
3.2.2 Global In-Vitro Diagnostic Instrumentations Market by Value
3.3 Global In-Vitro Diagnostic Market: Technology Analysis
3.3.1 Global In-Vitro Diagnostic Self Monitoring Blood Glucose (SMBG) Market by Value
3.3.2 Global In-Vitro Diagnostic Clinical Chemistry Market by Value
3.3.3 Global In-Vitro Diagnostic Immunodiagnostic Market by Value
3.3.4 Global In-Vitro Diagnostic Molecular Diagnostic Market by Value
3.3.5 Global In-Vitro Diagnostic Point of Care (POC) Market by Value
3.3.6 Global In-Vitro Diagnostic Microbiology Market by Value
3.3.7 Global In-Vitro Diagnostic Hematology Market by Value
4. REGIONAL MARKET ANALYSIS
4.1 The US In-Vitro Diagnostic Market: An Analysis
4.1.1 The US In-Vitro Diagnostic Market by Value
4.2 Europe In-Vitro Diagnostic Market: An Analysis
4.2.1 Europe In-Vitro Diagnostic Market by Value
4.3 Asia In-Vitro Diagnostic Market: An Analysis
4.3.1 Asia In-Vitro Diagnostic Market by Value
4.3.2 China In-Vitro Diagnostic Market by Value
4.4 ROW In-Vitro Diagnostic Market: An Analysis
4.4.1 ROW In-Vitro Diagnostic Market by Value
5. MARKET DYNAMICS
5.1 Growth Drivers
5.1.1 Rising Geriatric Population
5.1.2 Increasing Global Disposable Income
5.1.3 Increase In Obese Population
5.1.4 Rising Diabetic Population
5.1.5 Rising Global Healthcare Expenditure
5.1.6 Upsurge in Global Urban Population
5.2 Challenges
5.2.1 Ethical Issues
5.2.2 Lack of Proper Infrastructure
5.2.3 High Implementation Cost Involved
5.2.4 Stringent Government Regulations
5.3 Market Trends
5.3.1 Emerging Trend of Personalized medicine
5.3.2 Point-of-Care (POC) Technologies
5.3.3 Use of Biochips in IVD
6. COMPETITIVE LANDSCAPE
6.1 Global In-Vitro Diagnostic Market Players By Share
7. COMPANY PROFILES
7.1 Roche Holding
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategy
7.2 Danaher Corporation
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategy
7.3 Abbott Laboratories
7.3.1 Business Overview
7.3.2 Financial Overview
7.3.3 Business Strategy
7.4 Siemens Group
7.4.1 Business Overview
7.4.2 Financial Overview
7.4.3 Business Strategy
2. INTRODUCTION
2.1 Clinical Trials: An Overview
2.2 In-Vitro: An Overview
2.3 In-Vitro Diagnostic (IVD): An Overview
2.4 In-Vitro Diagnostic (IVD) Products: An Overview
2.5 In-Vitro Diagnostic (IVD) Technology: An Overview
2.6 In-Vitro Diagnostic (IVD) End Users: An Overview
2.7 In-Vitro Diagnostic (IVD) Research Flow: An Overview
3. GLOBAL MARKET ANALYSIS
3.1 Global In-Vitro Diagnostic Market: An Analysis
3.1.1 Global In-Vitro Diagnostic Market by Value
3.1.2 Global In-Vitro Diagnostic Market by Region
3.1.3 Global In-Vitro Diagnostic Market by Products
3.1.4 Global In-Vitro Diagnostic Market by Technology
3.1.5 Global In-Vitro Diagnostic Market by End Users
3.2 Global In-Vitro Diagnostic Market: Product Analysis
3.2.1 Global In-Vitro Diagnostic Reagents Market by Value
3.2.2 Global In-Vitro Diagnostic Instrumentations Market by Value
3.3 Global In-Vitro Diagnostic Market: Technology Analysis
3.3.1 Global In-Vitro Diagnostic Self Monitoring Blood Glucose (SMBG) Market by Value
3.3.2 Global In-Vitro Diagnostic Clinical Chemistry Market by Value
3.3.3 Global In-Vitro Diagnostic Immunodiagnostic Market by Value
3.3.4 Global In-Vitro Diagnostic Molecular Diagnostic Market by Value
3.3.5 Global In-Vitro Diagnostic Point of Care (POC) Market by Value
3.3.6 Global In-Vitro Diagnostic Microbiology Market by Value
3.3.7 Global In-Vitro Diagnostic Hematology Market by Value
4. REGIONAL MARKET ANALYSIS
4.1 The US In-Vitro Diagnostic Market: An Analysis
4.1.1 The US In-Vitro Diagnostic Market by Value
4.2 Europe In-Vitro Diagnostic Market: An Analysis
4.2.1 Europe In-Vitro Diagnostic Market by Value
4.3 Asia In-Vitro Diagnostic Market: An Analysis
4.3.1 Asia In-Vitro Diagnostic Market by Value
4.3.2 China In-Vitro Diagnostic Market by Value
4.4 ROW In-Vitro Diagnostic Market: An Analysis
4.4.1 ROW In-Vitro Diagnostic Market by Value
5. MARKET DYNAMICS
5.1 Growth Drivers
5.1.1 Rising Geriatric Population
5.1.2 Increasing Global Disposable Income
5.1.3 Increase In Obese Population
5.1.4 Rising Diabetic Population
5.1.5 Rising Global Healthcare Expenditure
5.1.6 Upsurge in Global Urban Population
5.2 Challenges
5.2.1 Ethical Issues
5.2.2 Lack of Proper Infrastructure
5.2.3 High Implementation Cost Involved
5.2.4 Stringent Government Regulations
5.3 Market Trends
5.3.1 Emerging Trend of Personalized medicine
5.3.2 Point-of-Care (POC) Technologies
5.3.3 Use of Biochips in IVD
6. COMPETITIVE LANDSCAPE
6.1 Global In-Vitro Diagnostic Market Players By Share
7. COMPANY PROFILES
7.1 Roche Holding
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategy
7.2 Danaher Corporation
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategy
7.3 Abbott Laboratories
7.3.1 Business Overview
7.3.2 Financial Overview
7.3.3 Business Strategy
7.4 Siemens Group
7.4.1 Business Overview
7.4.2 Financial Overview
7.4.3 Business Strategy
LIST OF FIGURES
Figure 1: Categories of Clinical Trials
Figure 2: In-Vitro Outline
Figure 3: Classification of In-Vitro Diagnostics (IVD)
Figure 4: In-Vitro Diagnostic (IVD) Products
Figure 5: In-Vitro Diagnostic (IVD) Technology
Figure 6: In- Vitro Diagnostic (IVD) End Users
Figure 7: Flow of IVD Research to a Globally IVD Regulated Industry
Figure 8: Global In-Vitro Diagnostic Market by Value; 2015-2016 (US$ Billion)
Figure 9: Global In-Vitro Diagnostic Market by Value; 207-2021; (US$ Billion)
Figure 10: Global In-Vitro Diagnostic Market by Region; 2016
Figure 11: Global In-Vitro Diagnostic Market by Products; 2016
Figure 12: Global In-Vitro Diagnostic Market by Technology; 2016
Figure 13: Global In-Vitro Diagnostic Market by End Users; 2016
Figure 14: Global In-Vitro Diagnostic Reagents Market by Value; 2015-2016 (US$ Billion)
Figure 15: Global In-Vitro Diagnostic Reagents Market by Value; 2017-2021 (US$ Billion)
Figure 16: Global In-Vitro Diagnostic Instrumentations Market by Value; 2015-2016 (US$ Billion)
Figure 17: Global In-Vitro Diagnostic Instrumentations Market by Value; 2017-2021 (US$ Billion)
Figure 18: Global In-Vitro Diagnostic Self Monitoring Blood Glucose (SMBG) Market by Value; 2016-2021 (US$ Billion)
Figure 19: Global In-Vitro Diagnostic Clinical Chemistry Market by Value; 2016-2021 (US$ Billion)
Figure 20: Global In-Vitro Diagnostic Immunodiagnostic Market by Value; 2016-2021 (US$ Billion)
Figure 21: Global In-Vitro Diagnostic Molecular Diagnostic Market by Value; 2016-2021 (US$ Billion)
Figure 22: Global In-Vitro Diagnostic Point of Care (POC) Market by Value; 2016-2021 (US$ Billion)
Figure 23: Global In-Vitro Diagnostic Microbiology Market by Value; 2016-2021 (US$ Billion)
Figure 24: Global In-Vitro Diagnostic Hematology Market by Value; 2016-2021 (US$ Billion)
Figure 25: The US In-Vitro Diagnostic Market by Value; 2016-2021 (US$ Billion)
Figure 26: Europe In-Vitro Diagnostic Market by Value; 2016-2021 (US$ Billion)
Figure 27: Asia In-Vitro Diagnostic Market by Value; 2016-2021 (US$ Billion)
Figure 28: China In-Vitro Diagnostic Market by Value; 2016-2021 (US$ Billion)
Figure 29: ROW In-Vitro Diagnostic Market by Value; 2016-2021 (US$ Billion)
Figure 30: Global Population Proportion Above 65 Years of Age; 2012-2016 (Billion)
Figure 31: Global GNI Per Capita and GNI Per Capita Growth Rate; 2010-2016 (US$)
Figure 32: Global Obese Population; 2012-2016 (Million)
Figure 33: Global Diabetic Population; 2012-2016 (Million)
Figure 34: Global Healthcare Expenditure; 2013-2018 (US$ Trillion)
Figure 35: Global Urban Population; 2012-2016 (Billion)
Figure 36: Global In-Vitro Diagnostic Market Players By Share; 2016
Figure 37: China In-Vitro Diagnostic Market Players By Share; 2016
Figure 38: Roche Holding Sales; 2012-2016 (US$ Billion)
Figure 39: Roche Holding Sales by Segments; 2016
Figure 40: Roche Holding Sales by Region; 2016
Figure 41: Danaher Corporation Sales; 2012-2016 (US$ Billions)
Figure 42: Danaher Corporation Sales by Segment; 2016
Figure 43: Danaher Corporation Sales by Region; 2016
Figure 44: Abbott Laboratories Net Sales; 2012-2016 (US$ Billion)
Figure 45: Abbott Laboratories Net Sales by Segments; 2016
Figure 46: Abbott Laboratories Net Sales by Region; 2016
Figure 47: Siemens Group Revenue; 2012-2016 (US$ Billion)
Figure 48: Siemens Group Revenue By Segment; 2016 (Percentage, %)
Figure 49: Siemens Group Revenue By Region; 2016
Figure 1: Categories of Clinical Trials
Figure 2: In-Vitro Outline
Figure 3: Classification of In-Vitro Diagnostics (IVD)
Figure 4: In-Vitro Diagnostic (IVD) Products
Figure 5: In-Vitro Diagnostic (IVD) Technology
Figure 6: In- Vitro Diagnostic (IVD) End Users
Figure 7: Flow of IVD Research to a Globally IVD Regulated Industry
Figure 8: Global In-Vitro Diagnostic Market by Value; 2015-2016 (US$ Billion)
Figure 9: Global In-Vitro Diagnostic Market by Value; 207-2021; (US$ Billion)
Figure 10: Global In-Vitro Diagnostic Market by Region; 2016
Figure 11: Global In-Vitro Diagnostic Market by Products; 2016
Figure 12: Global In-Vitro Diagnostic Market by Technology; 2016
Figure 13: Global In-Vitro Diagnostic Market by End Users; 2016
Figure 14: Global In-Vitro Diagnostic Reagents Market by Value; 2015-2016 (US$ Billion)
Figure 15: Global In-Vitro Diagnostic Reagents Market by Value; 2017-2021 (US$ Billion)
Figure 16: Global In-Vitro Diagnostic Instrumentations Market by Value; 2015-2016 (US$ Billion)
Figure 17: Global In-Vitro Diagnostic Instrumentations Market by Value; 2017-2021 (US$ Billion)
Figure 18: Global In-Vitro Diagnostic Self Monitoring Blood Glucose (SMBG) Market by Value; 2016-2021 (US$ Billion)
Figure 19: Global In-Vitro Diagnostic Clinical Chemistry Market by Value; 2016-2021 (US$ Billion)
Figure 20: Global In-Vitro Diagnostic Immunodiagnostic Market by Value; 2016-2021 (US$ Billion)
Figure 21: Global In-Vitro Diagnostic Molecular Diagnostic Market by Value; 2016-2021 (US$ Billion)
Figure 22: Global In-Vitro Diagnostic Point of Care (POC) Market by Value; 2016-2021 (US$ Billion)
Figure 23: Global In-Vitro Diagnostic Microbiology Market by Value; 2016-2021 (US$ Billion)
Figure 24: Global In-Vitro Diagnostic Hematology Market by Value; 2016-2021 (US$ Billion)
Figure 25: The US In-Vitro Diagnostic Market by Value; 2016-2021 (US$ Billion)
Figure 26: Europe In-Vitro Diagnostic Market by Value; 2016-2021 (US$ Billion)
Figure 27: Asia In-Vitro Diagnostic Market by Value; 2016-2021 (US$ Billion)
Figure 28: China In-Vitro Diagnostic Market by Value; 2016-2021 (US$ Billion)
Figure 29: ROW In-Vitro Diagnostic Market by Value; 2016-2021 (US$ Billion)
Figure 30: Global Population Proportion Above 65 Years of Age; 2012-2016 (Billion)
Figure 31: Global GNI Per Capita and GNI Per Capita Growth Rate; 2010-2016 (US$)
Figure 32: Global Obese Population; 2012-2016 (Million)
Figure 33: Global Diabetic Population; 2012-2016 (Million)
Figure 34: Global Healthcare Expenditure; 2013-2018 (US$ Trillion)
Figure 35: Global Urban Population; 2012-2016 (Billion)
Figure 36: Global In-Vitro Diagnostic Market Players By Share; 2016
Figure 37: China In-Vitro Diagnostic Market Players By Share; 2016
Figure 38: Roche Holding Sales; 2012-2016 (US$ Billion)
Figure 39: Roche Holding Sales by Segments; 2016
Figure 40: Roche Holding Sales by Region; 2016
Figure 41: Danaher Corporation Sales; 2012-2016 (US$ Billions)
Figure 42: Danaher Corporation Sales by Segment; 2016
Figure 43: Danaher Corporation Sales by Region; 2016
Figure 44: Abbott Laboratories Net Sales; 2012-2016 (US$ Billion)
Figure 45: Abbott Laboratories Net Sales by Segments; 2016
Figure 46: Abbott Laboratories Net Sales by Region; 2016
Figure 47: Siemens Group Revenue; 2012-2016 (US$ Billion)
Figure 48: Siemens Group Revenue By Segment; 2016 (Percentage, %)
Figure 49: Siemens Group Revenue By Region; 2016
